SER

Serina Therapeutics, Inc. Common Stock (SER)

About Serina Therapeutics, Inc. Common Stock (SER)

Serina Therapeutics, Inc. operates as a clinical-stage biotechnology company, which engages in the research and development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL.

Details

Daily high

$2.29

Daily low

$2.00

Price at open

$2.15

52 Week High

$5.83

52 Week Low

$1.22

Market cap

57.2M

Dividend yield

Volume

27,987

Avg. volume

58,748

P/E ratio

-1.20

Serina Therapeutics, Inc. Common Stock News